Literatur
- 1
Ardissino D, Cavallini C, Bramucci E, Indolfi C, Marzocchi A, Manari A, Angeloni G,
Carosio G, Bonizzoni E, Colusso S, Repetto M, Merlini P A.
Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary
arteries: a randomized trial.
Jama.
2004;
292
2727-2734
- 2
Bardy G H, Lee K L, Mark D B, Poole J E, Packer D L, Boineau R, Domanski M, Troutman C,
Anderson J, Johnson G, McNulty S E, Clapp-Channing N, Davidson-Ray L D, Fraulo E S,
Fishbein D P, Luceri R M, Ip J H.
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
N Engl J Med.
2005;
352
225-237
- 3
Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion J M.
Cardiovascular prognosis of „masked hypertension” detected by blood pressure self-measurement
in elderly treated hypertensive patients.
Jama.
2004;
291
1342-1349
- 4
Braunwald E, Domanski M J, Fowler S E, Geller N L, Gersh B J, Hsia J, Pfeffer M A,
Rice M M, Rosenberg Y D, Rouleau J L.
Angiotensin-converting-enzyme inhibition in stable coronary artery disease.
N Engl J Med.
2004;
351
2058-2068
- 5
Bristow M R, Saxon L A, Boehmer J, Krueger S, Kass D A, De Marco T, Carson P, DiCarlo L,
DeMets D, White B G, DeVries D W, Feldman A M.
Cardiac-resynchronization therapy with or without an implantable defibrillator in
advanced chronic heart failure.
N Engl J Med.
2004;
350
2140-2150
- 6
Cleland J G, Daubert J C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L.
The effect of cardiac resynchronization on morbidity and mortality in heart failure.
N Engl J Med.
2005;
352
1539-49
- 7
Colhoun H M, Betteridge D J, Durrington P N, Hitman G A, Neil H A, Livingstone S J,
Thomason M J, Mackness M I, Charlton-Menys V, Fuller J H.
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes
in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled
trial.
Lancet.
2004;
364
685-696
- 8
Grundy S M, Cleeman J I, Merz C N, Brewer H B, Clark L T, Hunninghake D B, Pasternak R C,
Smith S C, Stone N J.
Implications of recent clinical trials for the National Cholesterol Education Program
Adult Treatment Panel III guidelines.
Circulation.
2004;
110
227-239
- 9
Hohnloser S H, Kuck K H, Dorian P, Roberts R S, Hampton J R, Hatala R, Fain E, Gent M,
Connolly S J.
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial
infarction.
N Engl J Med.
2004;
351
2481-2488
- 10
LaRosa J C, Grundy S M, Waters D D, Shear C, Barter P, Fruchart J C, Gotto A M, Greten H,
Kastelein J J, Shepherd J, Wenger N K.
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
N Engl J Med.
2005;
352
1425-1435
- 11
Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold J M, Ross C, Arnold A, Sleight P,
Probstfield J, Dagenais G R.
Effects of long-term vitamin E supplementation on cardiovascular events and cancer:
a randomized controlled trial.
Jama.
2005;
293
1338-1347
- 12
Nissen S E, Tuzcu E M, Schoenhagen P, Brown B G, Ganz P, Vogel R A, Crowe T, Howard G,
Cooper C J, Brodie B, Grines C L, DeMaria A N.
Effect of intensive compared with moderate lipid-lowering therapy on progression of
coronary atherosclerosis: a randomized controlled trial.
Jama.
2004;
291
1071-1080
- 13
Wollert K C, Meyer G P, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S,
Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H.
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the
BOOST randomised controlled clinical trial.
Lancet.
2004;
364
141-148
Prof. Dr. med. Erland Erdmann
Klinik III für Innere Medizin, Universität zu Köln
Kerpener Straße 9
50937 Köln
Phone: 0221/4786465
Fax: 0221/4787929
Email: erland.erdmann@uni-koeln.de
